نتائج البحث - Barry Antonacci

  • يعرض 1 - 2 نتائج من 2
تنقيح النتائج
  1. 1
    In Vitro and In Vivo Activities of SCH 56592 (Posaconazole), a New Triazole Antifungal Agent, against <i>Aspergillus</i> and <i>Candida</i>

    In Vitro and In Vivo Activities of SCH 56592 (Posaconazole), a New Triazole Antifungal Agent, against <i>Aspergillus</i> and <i>Candida</i> حسب Anthony Cacciapuoti, David Loebenberg, Erik Corcoran, Fred Menzel, E. L. Moss, Christine Norris, Monika Michalski, Kimberly Raynor, Judith Halpern, Cara Mendrick, Brian M. Arnold, Barry Antonacci, Raulo Parmegiani, T. Yarosh-Tomaine, George H. Miller, R S Hare

    منشور في 2000
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  2. 2
    Discovery of a Novel Class of Orally Active Antifungal β-1,3- <scp>d</scp> -Glucan Synthase Inhibitors

    Discovery of a Novel Class of Orally Active Antifungal β-1,3- <scp>d</scp> -Glucan Synthase Inhibitors حسب Scott S. Walker, Yiming Xu, Ilias Triantafyllou, Michelle F. Waldman, Cara Mendrick, Nathaniel H. Brown, Paul A. Mann, Andrew S. Chau, Reena Patel, Nicholas P. Bauman, Christine Norris, Barry Antonacci, Maya Gurnani, Anthony Cacciapuoti, Paul M. McNicholas, Samuel B. Wainhaus, R. Jason Herr, Rongze Kuang, Robert Aslanian, Pauline C. Ting, Todd A. Black

    منشور في 2011
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:

أدوات البحث: